NewsDiscovery of nanosized molecules that might inhibit
Alzheimer’s and Parkinson’s diseases

1st July 2021by admin0
https://nfusion-tech.com/wp-content/uploads/2021/07/discovery-of-nanosized-molecules-that-might-inhibitalzheimers-and-parkinsons-diseases_60dee1337dfa6.jpeg

Nanosized molecules of a particular chemical element
can inhibit the formation of plaque in the brain tissues. This new
discovery by researchers at Umeå University, Sweden, in
collaboration with researchers in Croatia and Lithuania, provides
renewed hope for novel treatments of, for instance, Alzheimer’s and
Parkinson’s disease in the long run.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2021 New Fusion All Rights Reserved

      Designed by FallingBrick